iiinova — where your digital self keeps evolving

IHU Infiny @ihu-infiny.bsky.social · 22/04/2025

📢 [Abstract submission] Join us on Oct 15, 2025 for a full day dedicated to scientific research in #IBD and #inflammation — basic, translational & clinical. 🌍 Connect with researchers & clinicians from across disciplines. 👉Submit : www.ihu-infiny.fr/actualites/f... #IBD #CallForPapers #Futures2025

ihu-infiny.fr

FUTURES 2025 - ABSTRACT SUBMISSION – IHU INFINY

The Infiny IBD Institute annual abstract submission is now open. We invite researchers, clinicians, and healthcare professionals to submit abstracts for

010

IHU Infiny @ihu-infiny.bsky.social · 10/04/2025

[🔬 Conference – FR]💬 Better understand how environmental & systemic factors influence IBD (Inflammatory Bowel Disease). 📅 Fri, May 16 | 10:00–12:00 📍 IRIS Auditorium – Brabois Hospitals, Nancy 🔗 More info and free registration here: www.ihu-infiny.fr/agenda/confe...

ihu-infiny.fr

Conférence INFINY - Recherche fondamentale – IHU INFINY

La recherche dans les MICI : mieux comprendre les dimensions environnementales et systémiques - Vendredi 16 mai 2025

000

IHU Infiny @ihu-infiny.bsky.social · 25/03/2025

🔬 #TuesdayReading Congrats to @chassainglab.bsky.social , co-Scientific Director of IHU Infiny & Head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #GutMicrobes! ⬇️ 1/2

210

Reposted by IHU Infiny

IHU Infiny @ihu-infiny.bsky.social · 11/03/2025

🔬 #TuesdayReading Check out the March issue of @lancetgastrohep.bsky.social! 👋Congrats to Prof. Peyrin-Biroulet and the authors on their new study, highlighting the importance of achieving the right therapeutic balance for patients with inflammatory bowel disease (IBD) ⬇️

133

IHU Infiny @ihu-infiny.bsky.social · 11/03/2025

133

Reposted by IHU Infiny

The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social · 13/02/2025

The March issue of The Lancet Gastroenterology & Hepatology is out now at www.thelancet.com/gastrohep! Content includes: alcohol & cancer risk, colorectal cancer, inflammatory bowel disease, appendicitis, MASLD, viral hepatitis + more... #MedSky #GastroSky #LiverSky #IDSky #HepSky

0189

IHU Infiny @ihu-infiny.bsky.social · 11/02/2025

🔬 #TuesdayReading Congrats to Benoît Chassaing, co-scientific director of IHU Infiny & head of the Microbiota-Host Interactions team @institutpasteur.bsky.social, on his study in #Gut! 1/3⬇️

130

IHU Infiny @ihu-infiny.bsky.social · 10/02/2025

[#JOB] 📢 Sharing this great opportunity to work with an inspiring team! Ne manquez pas cette opportunité de travailler avec une équipe inspirante ! #apply #postulez

011

IHU Infiny @ihu-infiny.bsky.social · 27/01/2025

🗽IHU Infiny in NY! @chassainglab.bsky.social , Co-Director for basic research at Infiny & Head of the Microbiota-Host Interactions Unit at the @pasteur.fr, visited the Icahn School of Medicine at Mount Sinai, hosted by Prof. Saurabh Mehandru. 🚀 Stay tuned for exciting collaborations ahead.

031

IHU Infiny @ihu-infiny.bsky.social · 24/01/2025

👋 Hello Bluesky! We're thrilled to join the conversation here! At IHU Infiny, our mission is to advance research and innovation to enhance the lives of IBD patients. Let's connect and exchange ideas! ➡️ Follow us on: linktr.ee/ihu_infiny

010